CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.38
-0.02 (-0.37%)
At close: Jun 27, 2025, 4:00 PM
5.40
+0.02 (0.37%)
After-hours: Jun 27, 2025, 6:59 PM EDT
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
$575,829
Profits / Employee
$198,637
Market Cap
1.21B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CVAC News
- 4 days ago - CureVac Announces Voting Results of General Meeting - Accesswire
- 16 days ago - Top Stock Movers Now: Oracle, Boeing, CureVac, and More - Investopedia
- 16 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga
- 17 days ago - BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising. - Barrons
- 17 days ago - BioNTech to acquire CureVac in $1.25 billion all-stock deal - Reuters
- 5 weeks ago - CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates - Accesswire
- 6 weeks ago - CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE - Accesswire
- 2 months ago - CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript - Seeking Alpha